/
Familial Chylomicronemia Syndrome Familial Chylomicronemia Syndrome

Familial Chylomicronemia Syndrome - PowerPoint Presentation

pamella-moone
pamella-moone . @pamella-moone
Follow
367 views
Uploaded On 2018-11-01

Familial Chylomicronemia Syndrome - PPT Presentation

Case 1 Sheri Case 2 Sheris Son 18 years old Case Study 3 Severe Hypertriglyceridemia With Multifactorial Etiology Case Study 3 Severe Hypertriglyceridemia With Multifactorial Etiology cont ID: 708026

genetic case hypertriglyceridemia cont case genetic cont hypertriglyceridemia severe volanesorsen study fcs multifactorial etiology pancreatitis basis chylomicronemia points sheri

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Familial Chylomicronemia Syndrome" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Familial Chylomicronemia SyndromeSlide2
Slide3
Slide4

Case 1: SheriSlide5

Case 2: Sheri's Son (18 years old)Slide6

Case Study 3: Severe Hypertriglyceridemia With Multifactorial EtiologySlide7

Case Study 3: Severe Hypertriglyceridemia With Multifactorial Etiology (cont)Slide8

Case Study 3: Severe Hypertriglyceridemia With Multifactorial Etiology (cont)Slide9

Definition and Prevalence of FCSSlide10

Genetic Basis of Monogenic Forms: Genetic Mutations With Large EffectSlide11

Genetic Basis of Polygenic Forms: Genetic Mutations With Small EffectSlide12

Chylomicronemia Syndrome DiagnosisSlide13

Clinical Presentation, Testing and WorkupSlide14

Differential DiagnosisSlide15

Recurrent Episodes and Health BurdenSlide16

How Is FCS Pancreatitis Different From Other Pancreatitis? Slide17

Treatment Strategies for Pancreatitis Slide18

Message to PCPs and GI CliniciansSlide19

Cardiovascular Disease Risk Slide20

EPA and DHA: MOASlide21

Current and Emerging Management Options for FCSSlide22

VolanesorsenSlide23

Mean Percent Change in Lipid ParametersSlide24

Volanesorsen in Patients With Severe Hypertriglyceridemia -- Phase 3 Studies Slide25

Volanesorsen: MOA and Clinical ImpactSlide26

Take-Home PointsSlide27

Take-Home Points (cont)Slide28

AbbreviationsSlide29

Abbreviations (cont)